We want physicians and patients to feel comfortable about the medicines they choose. That’s why we’re committed to supporting awareness and education about biosimilar medicines at every level. This way, physicians and patients can feel confident that they’re making informed decisions about biosimilars.
Patients also benefit from effective education on biosimilars, which can help them feel confident and comfortable with the medicines they take. In addition to providing industry education, we also partner with providers, nurses, and advocacy groups to make sure patients get important information, so they feel comfortable with the medicines they receive.
By creating and cultivating this educational network, we strive to make seamless connections between the support community and our medicines that we hope will only continue to foster learning and knowledge sharing.
We promote access to all our medicines by investing in reimbursement services to make sure that tangible value also comes with our medicines. We’re continuously striving to make choosing an Amgen Biosimilar a better and optimal experience for health care systems, as well as patients.
Amgen leads with action by significantly investing in support, education programs, and reimbursement services to help ensure holistic value is integrated into every medicine.
Payers often endorse the preferences of prescribers when choosing biosimilars for their formularies, and prescribers may consider Amgen because of the comprehensive patient support services that come with every one of our medicines.
Choosing Amgen Biosimilars helps physicians, patients, and partners to have an optimal experience from the start.